Evidence map›Paper›PMID 38802531›Full record

ArticleCommunications biology2024

Mechanism of complement inhibition by a mosquito protein revealed through cryo-EM.

John F Andersen, Haotian Lei, Ethan C Strayer, Van Pham, José M C Ribeiro

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John F AndersenNIH-NIAID, Laboratory of Malaria and Vector Research, Rockville, MD, USA. john.andersen@nih.gov.ORCID 0000-0002-7686-3713
Haotian LeiNIH-NIAID, Research Technologies Branch, Bethesda, MD, USA.ORCID 0000-0002-4882-0249
Ethan C StrayerNIH-NIAID, Laboratory of Malaria and Vector Research, Rockville, MD, USA.
Van PhamNIH-NIAID, Laboratory of Malaria and Vector Research, Rockville, MD, USA.
José M C RibeiroNIH-NIAID, Laboratory of Malaria and Vector Research, Rockville, MD, USA.

Funding

Vector-Borne Diseases: Molecular Mechanisms in Vector-Host InteractionsZIAAI001012 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI RIBEIRO, JOSE · 2009 to 2025
$9.4M
6 · The paper itself

Abstract

Salivary complement inhibitors occur in many of the blood feeding arthropod species responsible for transmission of pathogens. During feeding, these inhibitors prevent the production of proinflammatory anaphylatoxins, which may interfere with feeding, and limit formation of the membrane attack complex which could damage arthropod gut tissues. Salivary inhibitors are, in many cases, novel proteins which may be pharmaceutically useful or display unusual mechanisms that could be exploited pharmaceutically. Albicin is a potent inhibitor of the alternative pathway of complement from the saliva of the malaria transmitting mosquito, Anopheles albimanus. Here we describe the cryo-EM structure of albicin bound to C3bBb, the alternative C3 convertase, a proteolytic complex that is responsible for cleavage of C3 and amplification of the complement response. Albicin is shown to induce dimerization of C3bBb, in a manner similar to the bacterial inhibitor SCIN, to form an inactive complex unable to bind the substrate C3. Size exclusion chromatography and structures determined after 30 minutes of incubation of C3b, factor B (FB), factor D (FD) and albicin indicate that FBb dissociates from the inhibited dimeric complex leaving a C3b-albicin dimeric complex which apparently decays more slowly.

Indexed as

AnophelesComplement C3bInsect ProteinsSalivary Proteins and PeptidesAmino Acid SequenceAnimalsComplement Inactivating AgentsCryoelectron MicroscopyHumansModels, Chemicalalbicin protein, Anopheles albimanusComplement C3bComplement Inactivating AgentsInsect ProteinsSalivary Proteins and Peptides

Identifiers

PMID38802531
PMCPMC11130238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.